| |
|
|
 |
April 29, 2013
Biolux Research Announces pilot study results and development of a new intraoral product for light accelerated orthodontics
VANCOUVER, B.C., CANADA – April 29, 2013 – Biolux Research Ltd. is very pleased to announce that the company has committed to development of a new photobiomodulation product (“OrthoPulse iO™”) for accelerating orthodontic treatment. To date the company has developed extraoral photobiomodulation technology and devices for dental applications involving bone regeneration, and is now focusing on an intraoral approach for orthodontics. The main benefits of intraoral photobiomodulation are increased clinical efficacy and a much shorter daily treatment session (a few minutes per arch), both of which are expected to lead to significant market acceptance and patient compliance.
|
 |
March 20, 2013
Biolux Research Announces significant research findings on light accelerated orthodontics at IADR/AADR General Session 2013
VANCOUVER, B.C., CANADA – March 20, 2013 – Biolux Research Ltd. is very pleased to announce that two sponsored research studies on important photobiomodulation results will be presented at the upcoming International Association of Dental Research / American Association of Dental Research General Session and Exhibition in Seattle Washington Mar 20 – 23, 2013. These presentations include clinical evaluation of both efficacy and safety of Biolux-patented Light Accelerated Orthodontics™ technology and devices.
|
|
February 4, 2013
Biolux Research Announces regional distribution partner for Middle East and North Africa
VANCOUVER, B.C., CANADA – Feb. 4, 2013 – Biolux Research Ltd. Is very pleased to announce a partnership with MAC International Medical Solutions LLC of Dubai, UAE, for the distribution of the OsseoPulse™ bone regeneration system for use in implantology and dental surgery. The distribution agreement includes the regional territory of the Middle East and North Africa (MENA), and is for a three year term.
|
|
November 19, 2012
Biolux Research Announces sponsorship of inaugural rapid orthodontics symposium at AEEDCc 2013 in Dubai, UAE
VANCOUVER, B.C., CANADA – Nov. 19, 2012 – Biolux Research Ltd. is pleased to announce that it is sponsoring the inaugural Rapid Orthodontics Symposium planned in conjunction with the 17th edition of the UAE International Dental Conference & Arab Dental Exhibition (AEEDC) in Dubai, UAE on February 6, 2013. The symposium is designed to bring together the leading experts in the world on various techniques and technologies related to accelerating orthodontic tooth movement, improving treatment efficiency, and reducing treatment timelines. The event is being developed by Dr. Donald J. Ferguson, Professor and Dean, European University College, Dubai Healthcare City, UAE.
|
|
July 25, 2012
Biolux Research Announces Appointment of Dr. Chung How Kau to Clinical and Scientific Advisory Board
VANCOUVER, B.C., CANADA – Jul. 25, 2012 – Biolux Research Ltd. is pleased to announce the appointment of Chung How Kau, BDS, MScD, MBA, PhD, MOrth, FDS, FFD (Ortho) FAMS (Ortho), Cert (Ortho) to our clinical and scientific advisory board. Dr. Kau is Chairman and Professor at the Department of Orthodontics, University of Alabama at Birmingham, USA, and is an accomplished orthodontist, researcher, educator, author, and international speaker in the orthodontics world. He has trained and worked previously at the National University in Singapore, at Cardiff University and at the University of Texas Health Science Center (see biography at http://www.dental.uab.edu/departments-and-programs/orthodontics/chung-h-kau.html).
|
|
June 5, 2012
Biolux Research Hosts Second Annual Light Accelerated Orthodontics and Bone Regeneration Clinical and Scientific Conference.
VANCOUVER, B.C., CANADA – Jun. 5, 2012 – Biolux Research is pleased to announce that it hosted its 2nd annual clinical and scientific conference on Light Accelerated Orthodontics and Bone Regeneration, May 3-4 in Waikiki, Hawaii. This exclusive event featured a keynote speaker who is a world leader in cardiac and stroke photobiomodulation research, and presentations by key investigators participating in Biolux-sponsored studies, ranging from cellular-level research through to complete orthodontic cases. The meeting was designed to share new research on the mechanisms and clinical effects of OrthoPulse™ photobiomodulation technology, and promote collaboration and discussion of the impact of light treatment on the practice of orthodontics.
|
|
March 13, 2012
Biolux Research announces start of
two additional clinical trials for
light-accelerated orthodontics
VANCOUVER, B.C., CANADA – Mar. 13, 2012 – Biolux Research Ltd. is pleased to announce the start of two new controlled and randomized clinical trials to investigate the effects of OrthoPulse phototherapy technology on orthodontic treatment and overall timelines. Both studies are designed to evaluate the effect of light treatment during the complete whole mouth orthodontic treatment protocol in treated groups compared to control groups. These clinical trials are also designed to evaluate any impact of light treatment on compliance (patient acceptance of treatment), patient lifestyle, post-adjustment discomfort, and any change in levels of medication.
|
|
January 20, 2012
Biolux Research Announces Allowance of Key Light Therapy Patent and Filing of New Light Accelerated Orthodontics Patent Applications
VANCOUVER, B.C., CANADA – Jan. 20, 2012 – Biolux Research Ltd. is pleased to announce that the European Patent Office recently communicated its intention to grant to Biolux a patent related to light therapy devices for treatment of bone disorders and biostimulation of bone and soft tissue. The patent specifically relates to Biolux’s proprietary devices for extra-oral photobiomodulation of the jaw for dental applications.
Biolux also announces the recent filings of two Patent Cooperation Treaty (PCT) patent applications for new apparatuses and methods for applying photobiomodulation, or light therapy, to orthodontic treatment and related procedures. PCT applications enable patent coverage in all countries that are parties to the treaty, which include all major orthodontic markets.
|
|
December 20, 2011
Biolux Research announces appointment of DR. Tim Shaughnessy to clinical and scientific advisory board
VANCOUVER, B.C., CANADA – Dec. 20, 2011 – Biolux Research Ltd. is pleased to announce the
appointment of Timothy G. Shaughnessy, D.D.S., M.S., as consulting orthodontist to Biolux. Dr. Shaughnessy
is an American Board of Orthodontics certified orthodontist, a Director of the Atlanta Orthodontic Study Group,
and a distinguished presenter having lectured extensively throughout US, Canada, Puerto Rico, and France on
“Comprehensive Orthodontics.” Dr. Shaughnessy studied orthodontics at University of North Carolina School of
Dentistry, and has over 25 years of private practice experience in Atlanta, Georgia. www.straightteethdoc.com/
In the role of consulting orthodontist on the Biolux Clinical and Scientific Advisory Board, Dr. Shaughnessy is to
review and advise on Biolux’s research and development programs, expand the network of orthodontists and
beta test sites for clinical evaluation of prototypes and products, and treat a series of cases/patients with the
OrthoPulse™ for clinical evaluation of efficacy and product validation.
|
|
December 14, 2011
Biolux Research Announces New Financing For Development of Light Accelerated Orthodontics Product
VANCOUVER, B.C., CANADA – Dec. 14, 2011 – Biolux Research Ltd. is pleased to announce that it has
raised CAD $2.4MM in new funding for the company. The funds were raised through a debt issue that is
convertible to common shares at the company’s option, and was fully subscribed by existing shareholders of the
company.
The proceeds of the financing are designated as working capital to continue the development of the
OrthoPulse™, a full mouth, extra-oral phototherapy device designed to compliment traditional orthodontic
treatment, and facilitate faster tooth movement and reduced treatment timelines. The funds are also targeted to
complete initial orthodontic human trials and expand the clinical roadmap of new studies and trials, and to
develop new technology and additional intellectual property. The new funds are anticipated to support the
company through to the commercial launch of the OrthoPulse™.
|
|
August 19, 2011
Biolux Research Announces Start of Significant Series of Clinical Trials for Light-Accelerated Orthodontics.
VANCOUVER, B.C., CANADA - August 19, 2011 - Biolux Research Ltd. is pleased to announce the start of a series of significant clinical trials to evaluate the effects of our proprietary Light Accelerated Orthodontics technology on the rates of orthodontic tooth movement plus related orthodontic issues.
The principal investigator for the study is Dr. Enis Guray at the Department of Orthodontics, Faculty of Dentistry, Erciyes University, Kayseri, Turkey. Dr. Guray and his team have been investigating the use of the Biolux light treatment, or photobiomodulation, technology in animal and human models for a range of orthodontic applications, and have published an article in the European Journal of Orthodontics, as previously reported.
|
|
March 4, 2011
Biolux Research Announces Start of Key Clinical Trial for Light-Accelerated Orthodontics.
VANCOUVER, B.C., CANADA - March 4, 2011 - Biolux Research Ltd. is pleased to announce the start of a clinical trial at Mahidol University in Bangkok, Thailand, to evaluate the effects of our phototherapy technology on orthodontic tooth movement and treatment timelines.
The principal investigator for the study is Dr Peerapong Santiwong DDS, PhD (Dental Science), a distinguished researcher and lecturer in orthodontics. Also participating in the study is Dr. Amornpong Vachiramon DDS, DBA, MSc (Maxillofacial Surgery), MSc (Orthodontics), Grad.Dip.Clin.Sc. (Oral Surg), an internationally renowned lecturer and leader in developing new clinical orthodontic protocols and systems. Mahidol University has continuously strived for educational excellence, outstanding research, leadership in healthcare services, and global outlook. Mahidol University's particular strength lies in its research excellence, and its Department of Orthodontics is renowned for the quality of its research. Ethics approval has been granted for the study by the institution.
|
|
January 26, 2011
Biolux Research Announces Publication 0f Research Paper on Phototherapy and Orthodontics.
VANCOUVER, B.C., CANADA - January 26, 2011 - Biolux Research Ltd. is pleased to announce the publication of a new research paper in the European Journal of Orthodontics. The paper, entitled ?Resonance frequency analysis of orthodontic miniscrews subjected to light-emitting diode photobiomodulation therapy,? was published in December 2010. The principal investigator for the study was Dr. Enis Guray at the Department of Orthodontics, Faculty of Dentistry, Erciyes University, Kayseri, Turkey. Dr. Guray and his team have been investigating the effects of the Biolux OsseoPulse™ LED photobiomodulation (e.g. light treatment) device in various animal and human models for a range of orthodontic applications.
|
|
January 13, 2011
Biolux Research Announces Filing of Two Additional Patent Applications for Phototherapy and Orthodontics.
VANCOUVER, B.C., CANADA - January 13, 2011 - Biolux Research Ltd. is pleased to announce the filing of two new US patent applications for the use of phototherapy in orthodontics. The applications relate to innovative methods and apparatuses for the use of light treatment technology in combination with advanced and alternative methods of orthodontic treatment, resulting in improved quality, speed, and control of tooth movement.
|
|
December 21, 2010
Biolux Research Announces Start of New Clinical Trial for Light-Accelerated Orthodontics.
VANCOUVER, B.C., CANADA - December 21, 2010 - Biolux Research Ltd. is pleased to announce the start of a long-term clinical trial to evaluate the effects of Biolux phototherapy technology on orthodontic tooth movement and treatment timelines. The goal of the trial is to evaluate the efficacy of phototherapy over the course of a complete, full mouth orthodontic treatment. The study will include over 40 orthodontic patients treated with traditional brackets and wires plus phototherapy, and the patients will be followed over the course of the treatment program, including post-treatment follow-up. Measures of tooth position and movement will be made periodically by physical measurement and imaging, and secondary measures of procedure acceptance, patient compliance, and product validation will also be collected.
|
|
December 14, 2010
Biolux Research Announces Filing of Patent Application for Phototherapy and Orthodontic Tooth Movement.
VANCOUVER, B.C., CANADA - December 14, 2010 - Biolux Research Ltd. is pleased to announce the filing of a new US patent application for the use of phototherapy and orthodontics. The invention relates to methods and apparatuses for use in orthodontics, and in particular to methods and apparatuses useful for accelerating, controlling or improving the quality of tooth movement during orthodontic treatment when using a range of orthodontic techniques and materials.
|
|
July 16, 2010
Biolux Research Announces
Financing For Continued Development of its Light Accelerated
Orthodontics Product
VANCOUVER, B.C., CANADA - July 16, 2010 - Biolux Research Ltd. is pleased to announce that it has recently raised over CAD $1MM as part of a new equity offering of common shares. The funds were raised through a convertible debt mechanism offered to existing shareholders and optionholders of the company in advance of a planned further offering to the broader investment community in the near future.
|
|
June 24, 2010
Biolux Research Announces
Filing of Patent Application for Regulation of Orthodontic
Tooth Movement
VANCOUVER, B.C., CANADA - June 24, 2010 - Biolux
Research Ltd. is pleased to announce the filing of a second
patent application for a method and apparatus for accelerating
and regulating orthodontic tooth movement with light treatment
technology. The company filed the application through
the Patent Cooperation Treaty process, which will allow
for expansion of patent protection to over 200 countries,
including all major markets of the world.
|
|
June 10, 2010
Biolux Research Announces
Presentation of Accelerated Orthodontic Study Results
at International Association for Dental Research General
Session 2010
VANCOUVER, B.C., CANADA - June 10, 2010 - Biolux
Research Ltd. is pleased to announce that important results
from our accelerated orthodontics research program will
be presented at the upcoming International Association
for Dental Research (IADR) General Session in Barcelona,
Spain, July 14-17, 2010. The IADR is the pre-eminent research
organization in the world of dentistry, with a mission
to advance research and increase knowledge for the improvement
of oral health worldwide, to support and represent the
oral health research community, and to facilitate the
communication and application of research findings. This
year’s meeting will be highly attended by more than
5000 members from all corners of the globe.
|
|
May 10, 2010
Biolux Research announces Presentation of
the Osseopulse™ at Ontario Dental Association
Annual Spring Meeting 2010
VANCOUVER, B.C., CANADA - May 10, 2010 - Biolux Research Ltd. is pleased to announce that the OsseoPulse? Bone Regeneration System has been selected for presentation in the New Products Forum at the Ontario Dental Association Annual Spring Meeting in Toronto May 13-15, 2010. The presentation will highlight the clinical treatment opportunities with the OsseoPulse™, an innovative light treatment product that stimulates bone regeneration, allowing the dentist to dramatically reduce time to load dental implants and to treat challenging cases with increased confidence. The forum is a classroom setting with interactive discussion, and the presentation is supported by Citagenix Inc, distributor of the OsseoPulse™ in Canada.
|
|
April 26, 2010
Biolux Research announces Design Award
for the Osseopulse™ Bone Regeneration
System for Implantology
VANCOUVER, B.C., CANADA - April 26, 2010 - Biolux Research Ltd. is pleased to announce that it has
received the prestigious red dot product design award for the OsseoPulse™ Bone Regeneration System, in
recognition of the innovative design of the medical product.
|
|
November 5, 2009
Biolux Research announces financing and investigational testing authorization for the development of a light accelerated orthodontics product
VANCOUVER, B.C., CANADA - November 5, 2009 - Biolux Research Ltd. is pleased to announce that it has issued $860,000 in new shares as part of a new equity offering of common shares.
The offering included a debt conversion vehicle to convert shareholder loans, in which the principle shareholders of the company converted the majority of promissory notes into new shares. The majority of the offering was purchased by Elac Venture Corporation, a private equity investing firm based in Hong Kong. The remainder of the offering was purchased by existing shareholders and individual investors.
|
|
August 13, 2009
Biolux Research announces
support from the National Research Council of Canada Industrial
Research Assistance Program for the development of light
accelerated orthodontics product.
VANCOUVER, B.C., CANADA - Aug. 13, 2009 - Biolux
Research Ltd. is pleased to announce that it has received
a non-repayable financial contribution from the National
Research Council of Canada Industrial Research Assistance
Program (NRC-IRAP) to help accelerate the development
and commercialization of a new light treatment device
for orthodontics. The new product will be designed to
significantly accelerate tooth movement during orthodontic
treatment, and thus radically reduce treatment times and
improve the experience for patients.
NRC-IRAP will contribute approximately CAD $205,000 over
the next 18 months to support the research and prototyping
of the device, to clinically test and validate the effectiveness
of the technology, and to develop a high quality, manufacturable
product. In addition to the contribution, NRC-IRAP will
provide both technical and business oriented advisory
services.
|
|
June 26, 2009
Biolux
Research Announces OsseoPulse™ Production Milestone
and Expanding Distribution.
VANCOUVER, B.C., CANADA - Jun. 26, 2009 - Biolux
Research Ltd. is pleased to announce today that we have
achieved a production milestone for our OsseoPulse™
Bone Regeneration System, and have expanded our product
distribution into additional markets.
Since launching the OsseoPulse™ in Canada in Oct.
2008, we have received regulatory clearance in Canada,
Korea, Israel, and Europe. Achieving CE Mark is a significant
achievement as it provides direct regulatory approval
for approximately 20 European countries.
|
|
June 15, 2009
Biolux
Research Announces Filing of Patent Application for Light
Accelerated Orthodontics.
VANCOUVER, B.C., CANADA - Jun. 15, 2009 - Biolux
Research Ltd. is pleased to announce today the filing
of a patent application for a method and apparatus for
accelerating orthodontics with light treatment technology.
Orthodontics is the dentistry specialty of moving teeth
within the jaw to provide better alignment and other benefits,
and is a very common dental procedure. There are approximately
10,000 orthodontists in the US and Canada, with approximately
2 million patients undergoing orthodontic treatment in
an average year. Orthodontic treatment is traditionally
achieved with appliances (braces) that provide physical
force to the teeth and move the roots through the bone.
Typical orthodontic treatments range from 12 to 36 months,
due to the natural limitations of bone resorption and
regeneration processes, and consist of frequent visits
to the orthodontist for adjustments and tightening. Reducing
overall treatment time can provide a much better experience
for the patient, including less social stigma, discomfort,
and change of diet, while accelerating the process presents
new opportunities to the orthodontist to provide different
and better care.
|
|
March 18, 2009
Biolux
Research Announces European Launch of the OsseoPulse?
Bone Regeneration System.
VANCOUVER, B.C., CANADA - Mar. 18, 2009 - Biolux
Research Ltd. is pleased to announce today that it will
be launching the OsseoPulse? Bone Regeneration System
at the 33rd International Dental Show from Mar. 24 - 29.
http://english.ids-cologne.de/
IDS 2009 in Cologne, Germany is the world's leading trade
show and sector meeting place for decision-makers from
dental practices, dental labs, the specialist dental trade,
the dental industry and from research and development.
More than 100,000 visitors gather information on new products
and innovations from some 1,750 exhibitors from 55 countries.
Launch of the OsseoPulse™ in Europe builds on recent
milestones of achieving both ISO 13485 certification and
CE Mark regulatory approval for the product. The CE Mark
allows Biolux to market the device directly to the 27
countries within the European Union plus the additional
4 countries that recognize the CE Mark. The dental implant
market in Europe represents approximately 40% of the worldwide
implant market, and is thus a significant market for Biolux
and the OsseoPulse™.
|
|
February 5, 2009
Biolux Research Announces
ISO 13485 Quality System Certification and CE Mark Regulatory
Approval of the OsseoPulse? Bone Regeneration System.
VANCOUVER, B.C., CANADA - Feb. 5, 2009 - Biolux
Research Ltd. is pleased to announce today two news items
that will further enhance the commercialization of its
OsseoPulse? Bone Regeneration System.
The company has successfully completed its ISO 13485 certification
audit and has been awarded a final certificate. ISO 13485
is a worldwide-recognized medical device quality system
standard, and certification to this standard is a requirement
for any medical device company to develop, manufacture,
and market products in Europe, Canada, and other markets.
The Biolux quality system was audited by BSI Management
Systems America Inc., one of the foremost auditing bodies
in the world.
|
|
December 1, 2008
Biolux Research Announces
Commercial Launch of the OsseoPulse? Bone Regeneration
System in Korea.
VANCOUVER, B.C., CANADA – Dec. 1, 2008
– Biolux Research Ltd. is pleased to announce today
that it has launched the OsseoPulse? Bone Regeneration
System in South Korea. The product is now available for
sale exclusively through DIO Implant Inc., a division
of publicly-traded Dong Seo Inc, under the distribution
agreement signed earlier in 2008. The product has been
approved by the Korean FDA as a Class II device, and product
has been shipped to DIO to begin marketing and sales of
the OsseoPulse? to luminaries and opinion leaders.
|
|
October 31, 2008
Biolux Research Announces
Launch of the OsseoPulse™ Bone Regeneration System
in Canada.
VANCOUVER, B.C., CANADA – Oct. 31, 2008
– Biolux Research Ltd. is pleased to announce today
that it has launched the OsseoPulse? Bone Regeneration
System in Canada. The product is now available for sale
through Citagenix Inc., our exclusive distribution partner.
The product has been approved by Health Canada as a class
II medical device, and received a medical device license
earlier in 2008. Production quality has been proven, sales
training has taken place, and product has been shipped
to Citagenix to begin marketing and sales.
|
|
August 20, 2008
Biolux Research Announces
Appointment of Dr. Cameron Clokie as Chair of Scientific
Advisory Board.
VANCOUVER, B.C., CANADA ? August 20,
2008 ? Biolux Research Ltd. Is very pleased to announce
that it has appointed Dr. Cameron Clokie, DDS, OMFS, PhD,
as Chair of its Scientific Advisory Board (SAB). Dr. Clokie
is renowned in the field of implantology, and was part
of the pioneering group to develop the clinical field
in Canada decades ago. For the past ten years Dr. Clokie
served as Head of Oral and Maxillofacial Surgery, Faculty
of Dentistry, University of Toronto, and is currently
a partner at very successful private practice in Toronto.
Dr. Clokie has also successfully commercialized numerous
dental products in the tissue regeneration space.
|
|
July 24, 2008
Biolux
Research Announces Agreement with Citagenix for Exclusive
Distribution of the OsseoPulse? Bone Regeneration System
in Canada.
VANCOUVER, B.C., CANADA ? July 24, 2008
? Biolux Research Ltd. announced today that it has signed
a new distribution agreement with Citagenix Inc. to commercialize
the OsseoPulse? Bone Regeneration System in Canada. The
agreement provides exclusivity and a long term commitment
necessary to introduce the new product to the Canadian
dental market.
|
|
May 7, 2008
Biolux
Research Announces Health Canada Regulatory Approval for
its OsseoPulse™
Bone Regeneration System.
VANCOUVER, B.C., CANADA - May 7, 2008
– Biolux Research Ltd. announced today that it has
received approval from Health Canada to market the OsseoPulse™
Bone Regeneration System in Canada. The OsseoPulse™
is classified by Health Canada as a Class II medical device,
and received a Medical Device Licence for the system and
its components. The licence was applied for in partnership
with StarFish Medical of Victoria, BC.
|
|
April 4, 2008
Biolux
Research Announces Appointment of President and CEO for
Commercialization
of its OsseoPulse™ Bone Regeneration System.
VANCOUVER, B.C., CANADA. - April
4, 2008 – Biolux
Research Ltd. announced today that it has appointed medical
device industry veteran Kevin Strange as President and
CEO. Mr. Strange’s primary responsibilities will
be to lead the commercialization of the unique OsseoPulse™
Bone Regeneration System for dentistry, including product
launch into Canada, the US, and Europe, as well as executing
work in Korea with our strategic partner DIO Implant,
subsidiary of a publicly listed medical device manufacturer
and distributor. Dr. Peter Brawn, Chairman and Founder
of Biolux, will continue the key roles of clinical and
scientific visionary and early product research and development.
|
| |
|
September 22, 2007
Biolux Research Announces
Memorandum of Understanding with Dong Seo Inc. of South
Korea
for its OsseoPulse™ Bone Regeneration System.
VANCOUVER, B.C., CANADA. - September
18, 2007 – Biolux
Research Ltd. announced today that it has signed a Memorandum
of Understanding (MOU) with DIO Implant, a wholly owned
subsidiary of Dong Seo Inc, which in turn is a KOSDAQ
stock exchange listed company and one of Korea’s
leading dental implant manufacturers. The MOU is for the
purpose of product evaluation, marketing and completion
of an exclusive distribution agreement for the OsseoPulse™
dental bone regeneration system in South Korea.
|
|
|
Biolux Research Ltd.